ANG Lifesciences

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE236W01016
  • NSEID:
  • BSEID: 540694
INR
21.90
-1.07 (-4.66%)
BSENSE

Mar 19

BSE+NSE Vol: 7.17 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002820,
    "name": "ANG Lifesciences",
    "stock_name": "ANG Lifesciences",
    "full_name": "ANG Lifesciences India Ltd",
    "name_url": "stocks-analysis/ang-lifesciences",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "21.90",
    "chg": -1.07,
    "chgp": "-4.66%",
    "dir": -1,
    "prev_price": "22.97",
    "mcapval": "30.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540694,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE236W01016",
    "curr_date": "Mar 19",
    "curr_time": "",
    "bse_nse_vol": "7.17 k",
    "exc_status": "Active",
    "traded_date": "Mar 19, 2026",
    "traded_date_str": "2026 03 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ang-lifesciences-1002820-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "ANG Lifesciences India Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-strong-sell-3846755",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ANGLifesciences_mojoScore_3846755.png",
        "date": "2026-02-19 10:10:50",
        "description": "ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2023. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "ANG Lifesciences Q3 FY26: Losses Deepen Amid Persistent Revenue Decline",
        "link": "https://www.marketsmojo.com/news/result-analysis/ang-lifesciences-q3-fy26-losses-deepen-amid-persistent-revenue-decline-3842779",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ANGLifesciences_quaterlyResult_3842779.png",
        "date": "2026-02-16 14:04:34",
        "description": "ANG Lifesciences India Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹33.00 crores, reported a quarterly net loss of ₹4.75 crores for Q3 FY26 ended December 2025, marking a 61.02% sequential deterioration from the previous quarter's loss of ₹2.95 crores. On a year-on-year basis, losses expanded 8.48% from ₹5.19 crores in Q3 FY25, as the company grapples with a sustained revenue contraction and negative operating margins."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-strong-sell-3825743",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ANGLifesciences_mojoScore_3825743.png",
        "date": "2026-02-07 10:10:32",
        "description": "ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2023. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 07 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "When is the next results date for ANG Lifesciences India Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-ang-lifesciences-india-ltd-3825269",
        "imagepath": "",
        "date": "2026-02-06 23:18:59",
        "description": "ANG Lifesciences India Ltd is scheduled to declare its results on 14 February 2026...."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-strong-sell-3771074",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ANGLifesciences_mojoScore_3771074.png",
        "date": "2025-12-26 15:13:06",
        "description": "ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Jun 2023. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook."
      }
    ],
    "total": 288,
    "sid": "1002820",
    "stock_news_url": "https://www.marketsmojo.com/news/ang-lifesciences-india-1002820"
  },
  "announcements": [
    {
      "caption": "Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025",
      "datetime": "14-Feb-2026",
      "details": "Unaudited Financial Results 31.12.2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025",
      "datetime": "14-Feb-2026",
      "details": "Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "06-Feb-2026",
      "details": "Revised Annual Secretarial Report for the year ended 31.03.2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has declared <strong>10%</strong> dividend, ex-date: 02 Nov 21",
          "dt": "2021-11-02",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has announced <strong>1:4</strong> bonus issue, ex-date: 13 Jul 22",
          "dt": "2022-07-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025

14-Feb-2026 | Source : BSE

Unaudited Financial Results 31.12.2025.

Board Meeting Outcome for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025

14-Feb-2026 | Source : BSE

Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025

Compliances-Reg.24(A)-Annual Secretarial Compliance

06-Feb-2026 | Source : BSE

Revised Annual Secretarial Report for the year ended 31.03.2025.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

ANG Lifesciences India Ltd has declared 10% dividend, ex-date: 02 Nov 21

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

ANG Lifesciences India Ltd has announced 1:4 bonus issue, ex-date: 13 Jul 22

stock-summary
RIGHTS

No Rights history available